Advisory Committee on Immunization Practices; Amended Notice of Meeting, 88780 [2024-26000]
Download as PDF
<![CDATA[
88780
Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–25986 Filed 11–7–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0072]
Advisory Committee on Immunization
Practices; Amended Notice of Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces an
amendment to the following meeting of
the Advisory Committee on
Immunization Practices (ACIP). This
meeting was open to the public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, Committee
Management Specialist, Advisory
Committee on Immunization Practices,
National Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H24–8,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–8836; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Advisory Committee on
Immunization Practices (ACIP); October
23, 2024, from 8 a.m. to 5:30 p.m., EDT,
and October 24, 2024, from 8 a.m. to
5:30 p.m., EDT (times subject to change;
see the ACIP website for updates:
https://www.cdc.gov/vaccines/acip/
index.html), in the original Federal
Register notice.
Notice of the virtual meeting was
published in the Federal Register on
September 30, 2024, 89 FR 79610–
79611.
The meeting notice is being amended
to update the recommendation votes in
the matters to be considered, which
should read as follows:
Matters to be Considered: The agenda
will include discussions on
chikungunya vaccines, COVID–19
vaccines, cytomegalovirus (CMV)
vaccine, Human papillomavirus (HPV)
vaccines, influenza vaccines,
meningococcal vaccines, mpox
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:38 Nov 07, 2024
Jkt 265001
vaccines, pneumococcal vaccines,
Respiratory Syncytial Virus (RSV)
vaccines for adults, RSV vaccines for
maternal and pediatric populations, and
the adult and child/adolescent
immunization schedules.
Recommendation votes are scheduled
for COVID–19 vaccines, meningococcal
vaccines, pneumococcal vaccines, and
the adult and child/adolescent
immunization schedules. A Vaccines for
Children (VFC) vote is scheduled for
influenza vaccines and meningococcal
vaccines. For more information on the
meeting agenda, visit https://
www.cdc.gov/acip/meetings/.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–26000 Filed 11–7–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–5054–N]
Medicare, Medicaid, Children’s Health
Insurance Program, Private Health
Insurance Program; Health Equity
Advisory Committee; Establishment &
Nomination Request
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
establishment of the Centers for
Medicare and Medicaid Services (CMS)
Health Equity Advisory Committee (the
‘‘Committee’’) and solicits nominations
for members to be appointed to the
Committee by the Director of the CMS
Office of Minority Health. The
Committee is established to advise and
make recommendations to CMS on the
identification and resolution of systemic
barriers to accessing CMS programs that
hinder quality of care for beneficiaries
and consumers. The Committee will
focus on health disparities in
underserved communities, which are
SUMMARY:
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
populations sharing a particular
characteristic, as well as geographic
communities, that have been
systematically denied a full opportunity
to participate in aspects of economic,
social, and civic life, such as but not
limited to Black, Latino, and Indigenous
and Native American persons, Asian
Americans and Pacific Islanders and
other persons of color; members of
religious minorities; lesbian, gay,
bisexual, transgender, and queer
persons; persons with disabilities;
persons who live in rural areas; and
persons otherwise adversely affected by
persistent poverty or inequality as
defined in the Executive Order,
Advancing Racial Equity and Support
for Underserved Communities Through
the Federal Government.
DATES: Nominations must be received
no later than December 12, 2024.
ADDRESSES: Nominations and requests
for copies of the Health Equity Advisory
Committee (HEAC) Charter may be
submitted to the address specified
below. Please do not submit duplicates.
Nominations or requests for copies of
the HEAC Charter must be submitted by
email to HEAC@cms.hhs.gov with the
subject line ‘‘HEAC Nomination’’ or
‘‘HEAC Request for Charter,’’ depending
on the content of the email.
FOR FURTHER INFORMATION CONTACT: Iris
Allen, Centers for Medicare & Medicaid
Services, HHS, at (410) 786–1633.
Press inquiries may be submitted by
phone at (202) 690–6145 or by email
press@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Health Equity Advisory
Committee (the ‘‘Committee’’ or
‘‘HEAC’’) is established to advise and
make recommendations to the Centers
for Medicare & Medicaid Services (CMS)
on the identification and resolution of
systemic barriers to accessing CMS
programs that hinder quality of care for
beneficiaries and consumers. Consistent
with Executive Order (E.O.) 13985,
Advancing Racial Equity and Support
for Underserved Communities through
the Federal Government,1 the
Committee will seek to advise and make
recommendations to CMS on ensuring
all eligible individuals can access CMS
programs and identify how CMS can
deliver benefits equitably to all people
enrolled in CMS programs. The
Committee will also serve as a dedicated
platform for CMS collaboration with key
interested persons to advance health
equity by identifying how CMS can
promote quality and access for
1 86
FR 7009, January 25, 2021.
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Page 88780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0072]
Advisory Committee on Immunization Practices; Amended Notice of
Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces an amendment
to the following meeting of the Advisory Committee on Immunization
Practices (ACIP). This meeting was open to the public.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Advisory Committee on Immunization Practices (ACIP);
October 23, 2024, from 8 a.m. to 5:30 p.m., EDT, and October 24, 2024,
from 8 a.m. to 5:30 p.m., EDT (times subject to change; see the ACIP
website for updates: https://www.cdc.gov/vaccines/acip/), in
the original Federal Register notice.
Notice of the virtual meeting was published in the Federal Register
on September 30, 2024, 89 FR 79610-79611.
The meeting notice is being amended to update the recommendation
votes in the matters to be considered, which should read as follows:
Matters to be Considered: The agenda will include discussions on
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine,
Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal
vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial
Virus (RSV) vaccines for adults, RSV vaccines for maternal and
pediatric populations, and the adult and child/adolescent immunization
schedules. Recommendation votes are scheduled for COVID-19 vaccines,
meningococcal vaccines, pneumococcal vaccines, and the adult and child/
adolescent immunization schedules. A Vaccines for Children (VFC) vote
is scheduled for influenza vaccines and meningococcal vaccines. For
more information on the meeting agenda, visit https://www.cdc.gov/acip/meetings/.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-26000 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P
